US · Healthcare

Benitec Biopharma Ltd ADR (BNTC)

Biotechnology

Benitec Biopharma Ltd ADR (BNTC) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for BNTC

P/E ratio

18.00

Benitec Biopharma Ltd ADR (BNTC) — FAQ

What is BNTC's P/E ratio?

The price-to-earnings (P/E) ratio for Benitec Biopharma Ltd ADR (BNTC) is 18.00 (data as of 2026-03-23).

Does Benitec Biopharma Ltd ADR pay a dividend?

Dividend yield is not available in the current snapshot for Benitec Biopharma Ltd ADR (BNTC). Check the MyAverix Finance app for the latest dividend data.

What sector is Benitec Biopharma Ltd ADR in?

Benitec Biopharma Ltd ADR (BNTC) is classified in the Healthcare sector (Biotechnology industry).

What exchange is BNTC listed on?

BNTC is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)